AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Virginia Tech at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Virginia Tech brings 2 presentations to AMP 2026 in Seattle. Its programme centres on measurable residual disease testing across blood cancers and solid tumours. The sessions cover personalised tumour-informed droplet digital PCR assays and what it takes to make residual disease testing in acute myeloid leukaemia routine practice.
| Organization | AMP 2026 Attendance |
|---|---|
Virginia Tech Blacksburg, VA | |
Public research university in Blacksburg, Virginia, with colleges of veterinary medicine, science and engineering and biomedical research institutes. | Workshop Wed, Nov 11 8:00am–8:50am MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours. Talk Sat, Nov 14 2:30pm–2:45pm Measurable Residual Disease Testing in Acute Myeloid Leukemia: Moving From Theory to Practice Measurable residual disease testing in acute myeloid leukemia: consensus guidance, where assays fall short, and how evidence is being built. |
Find decision makers at Virginia Tech
Tell us what you sell and we’ll find the people at Virginia Tech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction